J&J unit withdraws 2 lots of anti-seizure medicine Topamax

04/14/2011 | CNNMoney

Johnson & Johnson's Ortho-McNeil Neurologics unit recalled two lots of 100-milligram Topamax, a prescription drug for seizures, after receiving complaints about an "uncharacteristic odor." The drugmaker thinks the odor is caused by the chemical 2,4,6-tribromoanisole. The recall, which affects 57,000 bottles, is not expected to result in a shortage.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN